Semmelweis Symposium – 2018
Semmelweis Symposium 2018 program download
New approaches in personalized medicine: From prenatal testing to targeted tumor therapy
Budapest, November 8-9, 2018
Basic Science Center, Semmelweis University, Budapest (Tűzoltó 37-43, Budapest, 1094, Hungary)
Chairperson: Prof. Péter Lakatos
|
8th November |
|
|
9.00-9.15 |
Opening ceremony |
|
9.15-10.55 |
Section I. – Personalized Oncology I. |
|
9.15-9.35 |
Personalized medicine: What does that mean? István Takács, Semmelweis University, Budapest, Hungary |
|
9.35-9.55 |
Molecular biomarkers for the evaluation of colorectal cancer: Where are we now? Erika Tóth, Országos Onkológiai Intézet, Budapest, Hungary |
|
9.55-10.15 |
Every breast cancer patient needs chemotherapy? Magdolna Dank, Semmelweis University, Budapest, Hungary |
|
10.15-10.35 |
The role of RANK-RANKL in osteology and malignancies. Zsolt Nagy, Semmelweis University, Budapest, Hungary |
|
10.35-10.55 |
The evolution of molecular pathology; precision medicine in practice. Chris Allen, ThermoFisher Scientific, UK |
|
10.55-11.15 |
Coffee Break |
|
11.15-12.55 |
Section II. – Personalized Oncology II. |
|
11.15-11.35 |
The code and importance of liquid biopsy. Joao R. Carvalho, Biocartis, Mechelen, Netherlands |
|
11.35-11.55 |
BRCA1/2 genes in clinical practice. Edit Oláh, National Institute of Oncology, Budapest, Hungary |
|
11.55-12.15 |
The biology and application of cell-free nucleic acids in the clinical diagnosis. Bálint Nagy, Debrecen University, Debrecen, Hungary |
|
12.15-12.35 |
Personalized approach to thyroid nodules. Juan Carlos Galofré, University of Navarra, Pamplona, Spain |
|
12.35-12.55 |
Molecular diagnostics of thyroid cancers. Péter Lakatos, Semmelweis University, Budapest, Hungary |
|
12.55-14.00 |
Lunch |
|
14.00-15.20 |
Section III. – Prenatal genetics |
|
14.00-14.20 |
Non-invasive prenatal testing (NIPT). János P. Kósa, Semmelweis University, Budapest, Hungary |
|
14.20-14.40 |
SNP based NIPT, aneuploidy and single gene mutations. Trudy McKanna, Natera, San Carlos, CA, USA |
|
14.40-15.00 |
Comparative genomic hybridization arrays or conventional karyotyping? Olga Török, Debrecen Egyetem, Debrecen, Hungary |
|
15.00-15.20 |
Preimplantational diagnostics: designer babies? Péter Fancsovics, Semmelweis University, Budapest, Hungary |
|
15.20-15.40 |
Graduated diagnosis and personalized therapy of rare diseases in pediatrics. György Fekete, Semmelweis University, Budapest, Hungary |
|
15.40-16.00 |
Coffee Break |
|
16.00-17.20 |
Section IV. – Endocrinology / Osteology |
|
16.00-16.20 |
Sequential therapy of osteoporosis. Péter Lakatos, Semmelweis University, Budapest, Hungary |
|
16.20-16.40 |
Treatment of diabetes by stem cells. Antony Gavalas, Dresden University of Applied Sciences, Dresden,Germany |
|
16.40-17.00 |
Familial hypercholesterinemia – PCSK-9 inhibition. György Paragh, Debrecen University, Debrecen, Hungary |
|
17.00-17.20 |
High throughput methods in the evaluation of tumorigenesis in endocrine tumors. Attila Patócs, Semmelweis University, Budapest, Hungary |
|
|
|
|
19.00-22.00 |
Official Dinner Event (River Danube Experience) |
|
9th November |
|
|
9.00-10.40 |
Section V. – Hematology |
|
9.00-9.20 |
BITE-ing in the leukemia. Judit Demeter, Semmelweis University, Budapest, Hungary |
|
9.20-9.40 |
Personalized diagnostics and therapy in oncohematological malignancies. Csaba Bödör, Semmelweis University, Budapest, Hungary |
|
9.40-10.00 |
NGS in hematology. Torsten Haferlach, Münchner Leukämielabor, München, Germany |
|
10.00-10.20 |
Chimeric Antigen Receptor (CAR) T-Cell Therapy in hematology. Tamás Masszi, Semmelweis University, Budapest, Hungary |
|
10.20-10.40 |
Virus-specific T cell therapy in allogenic hematopoietic stem cell transplantation. Krisztián Kállay, Dél-Pesti Medical Center and National Institute for Hematology and Infectology, Budapest, Hungary |
|
10.40-11.00 |
Coffee Break |
|
11.00-13.00 |
Section VI. – Rare diseases |
|
11.00-11.20 |
Langerhans cell histiocytosis – from inflammation to malignancy. Michael Girschikofsky, Ordensklinikum, Linz, Austria |
|
11.20-11.40 |
Ending the diagnostic odyssey of rare diseases: NGS in the clinic. Kristóf Árvai, Semmelweis University, Budapest, Hungary |
|
11.40-12.00 |
Enzyme replacement therapies for lysosomal storage diseases. Francisca Coutinho, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal |
|
12.00-12.20 |
Live and let die. What genetics can offer for patients with cardiac disease: blessing or damn? Gábor Uzonyi, Uzsoki Hospital, Budapest, Hungary |
|
12.20-12.40 |
Whole exome sequencing in the management of rare diseases. Judit Mária Molnár, Semmelweis University, Budapest, Hungary |
|
12.40-13.40 |
Lunch |
|
13.40-15.20 |
Section VII. – Emerging Techniques |
|
13.40-14.00 |
Cell metabolism revealed: Agilent Seahorse XF, Svetoslav Kalaydiev, Agilent, Stockport, UK |
|
14.00-14.20 |
CRISPR / Base editing. Marie-Christine Birling, Institute Clinique de la Souris, Illkirch-Graffenstaden, France |
|
14.20-14.40 |
Lessons from limb regeneration in salamanders. Dunja Knapp, DFG- Center for Regenerative Therapies Dresden, Dresden, Germany |
|
14.40-15.00 |
Nanostring digital optical barcode technology: innovations in spatially resolved, library free multi-analyte expression analysis. Dr. Christoph Koenig, Nanostring Technologies, Seattle |
|
15.00-15.10 |
Closing remarks by Prof. Peter Lakatos |